Every day, more lives are transformed all over the world – one healthy habit at a time. Read the latest about how Medifast and the OPTAVIA® movement is impacting people’s lives.
Bradley T. MacDonald, CEO and Chairman of the Board for Medifast, Inc.
The cost of a Medifast program may now be tax deductible. The Internal Revenue Service (IRS) issued a new policy that states that "you may include in medical expenses the cost of a weight loss program under a physician's direction to treat an existing disease (such as heart disease)." The policy appears in IRS Publication 502 and is exciting news for the thousands of Americans using Medifast under their physician's care to treat a condition and improve specific health problems. The American Obesity Association recognizes more than 30 medical conditions that are directly associated with obesity. Obesity itself is listed as a disease in the International Classification of Diseases and is recognized by the World Health Organization and the U.S. Food and Drug Administration as a disease. This IRS policy does not include tax deductions for over-the-counter retail meal replacement products.
Medifast meal replacement programs are available at several different levels depending on the dieter's health and weight-loss goals. The programs feature highly engineered meal replacement products, supervision by qualified medical practitioners and quick and healthy weight loss (3-5 pounds per week for women and 4-6 pounds per week for men). Because of the protein/carbohydrate content of the Medifast products, dieters are not hungry and have plenty of energy. Most Medifast products include soy protein and meet the FDA "healthy heart" claim that "25 grams of soy protein per day, along with a diet low in saturated fat and cholesterol, may reduce the risk of heart disease." Each serving must have 6.25 grams of soy protein per serving to make this claim. Medifast revenues are up over 40% year-to-date and the company has recorded 6 consecutive quarters of profit.
SOURCE: Medifast, Inc.
Contact: Bradley T. MacDonald, CEO and Chairman of the Board of
Medifast, 410-581-8042 ext.231